These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 17908999)

  • 1. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas.
    Corsten MF; Miranda R; Kasmieh R; Krichevsky AM; Weissleder R; Shah K
    Cancer Res; 2007 Oct; 67(19):8994-9000. PubMed ID: 17908999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression.
    Shah K; Bureau E; Kim DE; Yang K; Tang Y; Weissleder R; Breakefield XO
    Ann Neurol; 2005 Jan; 57(1):34-41. PubMed ID: 15622535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
    Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
    Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand.
    Ehtesham M; Kabos P; Gutierrez MA; Chung NH; Griffith TS; Black KL; Yu JS
    Cancer Res; 2002 Dec; 62(24):7170-4. PubMed ID: 12499252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dual PI3K/mTOR inhibitor, PI-103, cooperates with stem cell-delivered TRAIL in experimental glioma models.
    Bagci-Onder T; Wakimoto H; Anderegg M; Cameron C; Shah K
    Cancer Res; 2011 Jan; 71(1):154-63. PubMed ID: 21084267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioresponsive tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene therapy for malignant brain tumors.
    Tsurushima H; Yuan X; Dillehay LE; Leong KW
    Cancer Gene Ther; 2007 Aug; 14(8):706-16. PubMed ID: 17541421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
    Chan JA; Krichevsky AM; Kosik KS
    Cancer Res; 2005 Jul; 65(14):6029-33. PubMed ID: 16024602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs.
    Xia H; Qi Y; Ng SS; Chen X; Li D; Chen S; Ge R; Jiang S; Li G; Chen Y; He ML; Kung HF; Lai L; Lin MC
    Brain Res; 2009 May; 1269():158-65. PubMed ID: 19265686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo.
    Shah K; Tang Y; Breakefield X; Weissleder R
    Oncogene; 2003 Oct; 22(44):6865-72. PubMed ID: 14534533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
    Liu C; Sarkaria JN; Petell CA; Paraskevakou G; Zollman PJ; Schroeder M; Carlson B; Decker PA; Wu W; James CD; Russell SJ; Galanis E
    Clin Cancer Res; 2007 Dec; 13(23):7155-65. PubMed ID: 18056196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models.
    Pisati F; Belicchi M; Acerbi F; Marchesi C; Giussani C; Gavina M; Javerzat S; Hagedorn M; Carrabba G; Lucini V; Gaini SM; Bresolin N; Bello L; Bikfalvi A; Torrente Y
    Cancer Res; 2007 Apr; 67(7):3054-63. PubMed ID: 17409412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and canstatin gene suppression therapy on breast tumor xenograft growth in mice.
    Wang WB; Zhou YL; Heng DF; Miao CH; Cao YL
    Breast Cancer Res Treat; 2008 Jul; 110(2):283-95. PubMed ID: 17899369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis.
    Shah K; Tung CH; Breakefield XO; Weissleder R
    Mol Ther; 2005 Jun; 11(6):926-31. PubMed ID: 15922963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The mechanism of apoptosis in human U87 glioma cells induced by miR-21 antisense oligonucleotide].
    Shi L; Cheng Z; Zhang J; Li R; You Y; Fu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):497-501. PubMed ID: 18841558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radio-responsive TRAIL gene therapy for malignant gliomas.
    Kyritsis AP; Rao JS; Puduvalli VK
    Cancer Gene Ther; 2007 Dec; 14(12):1002. PubMed ID: 17704752
    [No Abstract]   [Full Text] [Related]  

  • 18. Synergistic antitumoral effects of human telomerase reverse transcriptase-mediated dual-apoptosis-related gene vector delivered by orally attenuated Salmonella enterica Serovar Typhimurium in murine tumor models.
    Fu W; Chu L; Han X; Liu X; Ren D
    J Gene Med; 2008 Jun; 10(6):690-701. PubMed ID: 18338832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins.
    Tagscherer KE; Fassl A; Campos B; Farhadi M; Kraemer A; Böck BC; Macher-Goeppinger S; Radlwimmer B; Wiestler OD; Herold-Mende C; Roth W
    Oncogene; 2008 Nov; 27(52):6646-56. PubMed ID: 18663354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo.
    de Groot JF; Liu TJ; Fuller G; Yung WK
    Cancer Res; 2005 Mar; 65(5):1934-40. PubMed ID: 15753393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.